| PERIOD ENDING | 30-Sep-08 | | Total Revenue | 33,219 | | Cost of Revenue | 4,258 | | | Gross Profit | 28,961 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 7,900 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 21,061 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (16,886) | | Earnings Before Interest And Taxes | 4,175 | | Interest Expense | 917 | | Income Before Tax | 3,258 | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | 3,258 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 3,258 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $3,258 |
|
0.22% Nasdaq 0.00%
Income Statement
